The Advanced Practice Registered Nurse as a Prescriber

1 Cover

2 Title Page

3 Copyright Page

4 Dedication Page

5 Contributors

6 Preface

7 1 What Do APRN Prescribers Need to Understand? THE JOURNEY OF APRN PRESCRIPTIVE AUTHORITY OVERVIEW OF CHAPTERS CONCLUSION REFERENCES

8 2 Embracing the PrescriberRole as an APRN DEVELOPMENT OF THE APRN ROLE DEVELOPMENT OF THE APRN ROLE AND PRESCRIPTIVE AUTHORITY ADAPTING TO THE APRN’S ROLE AS PRESCRIBER BARRIERS TO TRANSITIONING TO THE PRESCRIBER ROLE A FRAMEWORK FOR PRESCRIBING SPECIAL CONSIDERATIONS FOR PRESCRIBING THE FUTURE OF THE APRN PRESCRIBING ROLE REFERENCES

9 3 Creating a Practice Environmentfor Full Prescriptive Authority EXTERNAL BARRIERS TO PRESCRIBING INTERNAL BARRIERS TO PRESCRIBING STRATEGIES TO ADDRESS PRESCRIBING BARRIERS ELIMINATING EXTERNAL BARRIERS TO PRESCRIBING ELIMINATING INTERNAL BARRIERS TO PRESCRIBING IMPLICATIONS REFERENCES

10 4 Regulation of PrescriptiveAuthority A MODEL FOR APRN FULL PRACTICE AUTHORITY CONSENSUS MODEL FOR APRN REGULATION HISTORY OF APRN PRESCRIBING REGULATION AUTONOMOUS PRESCRIPTIVE AUTHORITY OTHER REGULATORY REQUIREMENTS PRESCRIPTIVE AUTHORITY LIMITATIONS CONCLUSION REFERENCES

11 5 Global Prescribing DEFINING THE ADVANCED PRACTICE NURSE GLOBALLY COUNTRIES WITH ADVANCED PRACTICE ROLES TASK SHARING NURSE PRESCRIBING OUTCOMES OF NURSE PRESCRIBING APRN PRESCRIBING CONCLUSION REFERENCES

12 6 Managing Difficult andComplex Patient Interactions KNOWLEDGE OF SELF AS THE FOUNDATION FOR PROFESSIONAL GROWTH MOTIVATIONAL INTERVIEWING AS THE FOUNDATION FOR COUNSELING ABOUT CHANGE ETHICAL CONSIDERATIONS WHEN DEALING WITH DIFFICULT AND COMPLEX PATIENT INTERACTIONS ENGAGING PATIENTS WITH SUBSTANCE‐RELATED CONCERNS THE OPIOID EPIDEMIC AS A PROMPT FOR DIFFICULT CONVERSATIONS MANAGING INTERACTIONS THAT CAN LEAD TO BOUNDARY VIOLATIONS ENGAGING PATIENTS WITH BEHAVIORAL HEALTH ISSUES SOMATIC SYMPTOMS AND RELATED DISORDERS RESPONDING TO A REQUEST FOR INAPPROPRIATE TREATMENT PATIENT ISSUES ABOUT THEIR TREATMENT RECOMMENDATIONS CONCLUSION REFERENCES

13 7 Practical Considerations when Prescribing Controlled Substances DEFINITIONS RELATED TO CONTROLLED SUBSTANCES THE OPIOID EPIDEMIC BEST PRACTICES WHEN PRESCRIBING CONTROLLED SUBSTANCES CLINICAL GUIDELINES AND CONSENSUS STATEMENTS CLINICAL GUIDANCE FOR BENZODIAZEPINES AND OTHER CONTROLLED SUBSTANCES ASSESSMENT OF PATIENTS PRIOR TO INITIATING A CONTROLLED SUBSTANCE INITIATING CONTROLLED SUBSTANCE PRESCRIPTIONS MONITORING OF PATIENTS RECEIVING CONTROLLED SUBSTANCE PRESCRIPTIONS STRATEGIES FOR TAPER AND DISCONTINUATION OF CONTROLLED SUBSTANCES CONCLUSION REFERENCES

14 8 Legal Aspects of Prescribing WHAT DO ADVANCED PRACTICE REGISTERED NURSE (APRN) PRESCRIBERS NEED TO KNOW ABOUT THE LAW? CASES INVOLVING BOARDS OF NURSING CASES INVOLVING CONSULTATION WITH ATTORNEYS CASES INVOLVING THE DEA CASES INVOLVING GOVERNMENT AUDITORS SUMMARY PUBLIC ACCESS TO LICENSURE STATUS, AND BOARD AND CIVIL ACTIONS FEDERAL PRESCRIBING LAWS STATE LAWS ON PRESCRIBING LIABILITY INSURANCE CONCLUSION DISCLAIMER REFERENCES

15 9 Medical Marijuana and the APRN DEFINITIONS PHARMACOLOGY LEGALIZATION AUTHORIZATIONS THE EVIDENCE BASE FOR MEDICAL MARIJUANA CONCLUSION REFERENCES

16 Index

17 End User License Agreement

1 Chapter 2 Table 2.1 Nurse practitioners’ experience during the first year of primary ca...

2 Chapter 5Table 5.1 Nurse prescribing within the nurse’s specialty

3 Chapter 8Table 8.1 Selected frequency and severity of allegations related to medicatio...

4 Chapter 9Table 9.1 Qualifying conditions in states in which one or more APRN role can ...

1 Chapter 7Figure 7.1 National drug overdose deaths, number among all ages, 1999–2018 (...Figure 7.2 National drug overdose deaths involving benzodiazepines, by opioi...

1 Cover

2 Table of Contents

3 Begin Reading

1 iii

2 iv

3 v

4 ix

5 xi

6 1

7 2

8 3

9 4

10 5

11 6

12 7

13 8

14 9

15 10

16 11

17 12

18 13

19 14

20 15

21 16

22 17

23 18

24 19

25 20

26 21

27 22

28 23

29 24

30 25

31 27

32 28

33 29

34 30

35 31

36 32

37 33

38 34

39 35

40 36

41 37

42 38

43 39

44 40

45 41

46 42

47 43

48 45

49 46

50 47

51 48

52 49

53 50

54 51

55 52

56 53

57 54

58 55

59 56

60 57

61 58

62 59

63 60

64 61

65 62

66 63

67 65

68 66

69 67

70 68

71 69

72 70

73 71

74 72

75 73

76 74

77 75

78 76

79 77

80 78

81 79

82 80

83 81

84 82

85 83

86 85

87 86

88 87

89 88

90 89

91 90

92 91

93 92

94 93

95 94

96 95

97 96

98 97

99 98

100 99

101 100

102 101

103 102

104 103

105 104

106 105

107 106

108 107

109 108

110 109

111 110

112 111

113 112

114 113

115 114

116 115

117 116

118 117

119 118

120 119

121 120

122 121

123 122

124 123

125 124

126 125

127 126

128 127

129 128

130 129

131 130

132 131

133 132

134 133

135 134

136 135

137 136

138 137

139 138

140 139

141 140

142 141

143 142

144 143

145 144

146 145

147 146

148 147

149 148

150 149

151 150

152 151

153 152

154 153

155 154

156 155

157 156

158 157

159 158

160 159

161 160

162 161

163 162

164 163

165 164

166 165

167 166

168 167

169 168

170 169

171 170

172 171

173 172

174 173

175 174

176 175

177 176

178 177

179 178

180 179

181 180

182 181

183 182

184 183

185 184

186 185

187 186

188 187

189 188

190 191

191 189

192 190

193 192

194 193

195 194

196 195

197 196

198 197

199 198

200 199

201 200

202 201

203 202

204 203

205 204

206 205

207 206

208 207

209 208

SECOND EDITION

Edited by

Louise Kaplan

PhD, ARNP, FNP‐BC, FAANP, FAAN

Associate Professor

Washington State University

Vancouver, WA

Marie Annette Brown

PhD, ARNP, FNP‐BC, FAANP, FAAN

Professor Emeritus

University of Washington

Seattle, WA

This edition first published 2021

© 2021 John Wiley & Sons Ltd

All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by law. Advice on how to obtain permission to reuse material from this title is available at http://www.wiley.com/go/permissions.

The right of Louise Kaplan and Marie Annette Brown to be identified as the authors of the editorial material in this work has been asserted in accordance with law.